Evidence map›Paper›PMID 34580649›Full record

ArticleAmerican journal of ophthalmology case reports2021

Transient visual field loss after COVID-19 vaccination: Experienced by ophthalmologist, case report.

Chaisiri Jumroendararasame, Somboon Panyakorn, Rittirak Othong, Auraya Jumroendararasame, Worapot Srimanan, Kun Tipparut

Open access · goldAbstract readCase Reports
In one paragraph

Article in American journal of ophthalmology case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Chaisiri JumroendararasameDepartment of Ophthalmology, Phramongkutklao Hospital, Bangkok, Thailand.
Somboon PanyakornDepartment of Ophthalmology, Phramongkutklao Hospital, Bangkok, Thailand.
Rittirak OthongMedical Toxicology Unit, Department of Emergency Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.
Auraya JumroendararasameDepartment of Ophthalmology, Bangkok Metropolitan Administration General Hospital, Bangkok, Thailand.
Worapot SrimananDepartment of Ophthalmology, Phramongkutklao Hospital, Bangkok, Thailand.
Kun TipparutDepartment of Ophthalmology, Phramongkutklao Hospital, Bangkok, Thailand.
Phramongkutklao Hospital · THBangkok Metropolitan Administration · THNavamindradhiraj University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe first reported case of bilateral transient visual field defect, experienced by an ophthalmologist, which developed shortly after COVID-19 vaccination (CoronaVac, Sinovac Biotech Ltd., Beijing, China) and confirmed by computerized automated perimetry. OBSERVATION: The patient is a 42-year-old Thai ophthalmologist. He developed blurred vision within an hour after the second dose of COVID-19 vaccination. We described his self-observed of sequential symptoms, chronologic events, and management steps. The visual field of left congruous hemianopia with respect to vertical midline was detected with computerized automated perimetry. The possible mechanism could be related to an acute vasospasm of the artery in the postchiasmatic visual pathway, triggered by COVID-19 vaccine, Corona Vac. CONCLUSION AND IMPORTANCE: With increasing use of the COVID-19 vaccine in the near future, it would be prudent for medical staff and ophthalmologists to be considered and aware of this associated condition.

Indexed as

Case reportCoronaVacCOVID-19 vaccineSinovacVisual field defect

Identifiers

PMID34580649
PMCPMC8457908
OpenAlexW3202705400

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.